Compare $ALLO vs $OVID | Chartloom

Compare

$ALLO vs $OVID

Allogene Therapeutics Inc · Ovid Therapeutics Inc

ALLO

Allogene Therapeutics Inc

OVID

Ovid Therapeutics Inc

Compare $ALLO vs $OVID

Comparing Allogene Therapeutics Inc and Ovid Therapeutics Inc

ALLOAllogene Therapeutics Inc

OVIDOvid Therapeutics Inc

ALLOAllogene Therapeutics Inc

Market cap

$504M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

39,713.68x

Rev growth (TTM)

—

YTD performance

8.1%

52W performance

-0.7%

FCF yield

-20.4%

OVIDOvid Therapeutics Inc

Market cap

$459M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

1,284.26x

Rev growth (TTM)

-76.2%

YTD performance

39.8%

52W performance

55.7%

FCF yield

-11.9%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

ALLO

OVID

Detailed metrics comparison

ALLO

Allogene Therapeutics Inc

OVID

Ovid Therapeutics Inc

Market Cap

ALLO$504M

OVID$459M

Enterprise Value

ALLO$465M

OVID$448M

Price

ALLO$1.46

OVID$2.46

P/E Ratio

ALLON/A

OVIDN/A

P/S Ratio

ALLO108.60x

OVID290.04x

EV/Sales

ALLO100.28x

OVID282.89x

EV/EBITDA

ALLO0.00x

OVID3.65x

P/B Ratio

ALLO1.19x

OVID2.21x

P/FCF Ratio

ALLON/A

OVIDN/A

EV/FCF

ALLO-4.54x

OVID-8.18x

PEG Ratio

ALLON/A

OVIDN/A

Forward P/E (NTM)

ALLON/A

OVIDN/A

Forward P/S (NTM)

ALLO39,713.68x

OVID1,284.26x

Revenue (TTM)

ALLO$5M

OVID$2M

Revenue Growth (YoY)

ALLON/A

OVID-76.2%

Forward Rev Growth

ALLO219.7%

OVID-72.6%

Gross Margin (TTM)

ALLO0.0%

OVID0.0%

Operating Margin (TTM)

ALLO0.0%

OVID0.0%

EBITDA Margin (TTM)

ALLO-2703.1%

OVID-3681.4%

Net Margin (TTM)

ALLO-2648.4%

OVID-2178.9%

FCF Margin (TTM)

ALLO-2211.2%

OVID-3460.1%

Net Income (TTM)

ALLO$-123M

OVID$-34M

FCF (TTM)

ALLO$-103M

OVID$-55M

EPS (TTM)

ALLO-$0.37

OVID-$0.17

ROE (TTM)

ALLO-3531.0%

OVID-2364.0%

ROA (TTM)

ALLO-2622.0%

OVID-2052.0%

ROIC (TTM)

ALLO-3531.0%

OVID-2364.0%

Cash

ALLO$39M

OVID$11M

Debt

ALLO$0

OVID$0

Net Cash/Debt

ALLO$39M

OVID$11M

Current Ratio (TTM)

ALLO10.72x

OVID12.39x

Quick Ratio (TTM)

ALLO10.55x

OVID11.75x

Debt/Equity (TTM)

ALLO0.00x

OVID0.00x

Debt/Assets (TTM)

ALLO0.0%

OVID0.0%

Interest Coverage (TTM)

ALLON/A

OVIDN/A

Net Debt/EBITDA (TTM)

ALLO0.00x

OVID0.00x

Beta

ALLO0.75

OVID0.28

52W Performance

ALLO-0.7%

OVID55.7%

YTD Performance

ALLO8.1%

OVID39.8%

% from 52W High

ALLO-67.3%

OVID-20.8%

% from 52W Low

ALLO40.4%

OVID108.5%

Asset Turnover (TTM)

ALLO0.01x

OVID0.01x

FCF Yield (TTM)

ALLO-20.4%

OVID-11.9%

Earnings Yield (TTM)

ALLO-24.4%

OVID-7.5%

Dividend Yield (TTM)

ALLON/A

OVIDN/A

Rule of 40

ALLO-2,211.2

OVID-3,536.3

EV/GP/RG

ALLON/A

OVIDN/A

Ticker research

View ALLO research View OVID research

Metric	ALLO Allogene Therapeutics Inc	OVID Ovid Therapeutics Inc
Market & Valuation
Market Cap	$504M	$459M
Enterprise Value	$465M	$448M
Price	$1.46	$2.46
P/E Ratio	N/A	N/A
P/S Ratio	108.60x	290.04x
EV/Sales	100.28x	282.89x
EV/EBITDA	0.00x	3.65x
P/B Ratio	1.19x	2.21x
P/FCF Ratio	N/A	N/A
EV/FCF	-4.54x	-8.18x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	39,713.68x	1,284.26x
Revenue & Growth
Revenue (TTM)	$5M	$2M
Revenue Growth (YoY)	N/A	-76.2%
Forward Rev Growth	219.7%	-72.6%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-2703.1%	-3681.4%
Net Margin (TTM)	-2648.4%	-2178.9%
FCF Margin (TTM)	-2211.2%	-3460.1%
Net Income (TTM)	$-123M	$-34M
FCF (TTM)	$-103M	$-55M
EPS (TTM)	-$0.37	-$0.17
ROE (TTM)	-3531.0%	-2364.0%
ROA (TTM)	-2622.0%	-2052.0%
ROIC (TTM)	-3531.0%	-2364.0%
Financial Health
Cash	$39M	$11M
Debt	$0	$0
Net Cash/Debt	$39M	$11M
Current Ratio (TTM)	10.72x	12.39x
Quick Ratio (TTM)	10.55x	11.75x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.75	0.28
52W Performance	-0.7%	55.7%
YTD Performance	8.1%	39.8%
% from 52W High	-67.3%	-20.8%
% from 52W Low	40.4%	108.5%
Efficiency & Yields
Asset Turnover (TTM)	0.01x	0.01x
FCF Yield (TTM)	-20.4%	-11.9%
Earnings Yield (TTM)	-24.4%	-7.5%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-2,211.2	-3,536.3
EV/GP/RG	N/A	N/A
Ticker research	View ALLO research	View OVID research

Valuation

P/S Ratio

ALLO

108.60x

OVID

290.04x

EV/FCF

OVID

-8.18x

ALLO

-4.54x

Growth & revenue

Revenue Growth TTM

OVID

-76.2%

Forward Revenue Growth

ALLO

219.7%

OVID

-72.6%

Profitability & performance

Gross Margin

ALLO

0.0%

OVID

0.0%

ROE

OVID

-2364.0%

ALLO

-3531.0%

FCF Yield %

OVID

-11.9%

ALLO

-20.4%

52-Week Performance

OVID

55.7%

ALLO

-0.7%

Detailed metrics comparison

ALLO

Allogene Therapeutics Inc

OVID

Ovid Therapeutics Inc

Market Cap

ALLO$504M

OVID$459M

Enterprise Value

ALLO$465M

OVID$448M

Price

ALLO$1.46

OVID$2.46

P/E Ratio

ALLON/A

OVIDN/A

P/S Ratio

ALLO108.60x

OVID290.04x

EV/Sales

ALLO100.28x

OVID282.89x

EV/EBITDA

ALLO0.00x

OVID3.65x

P/B Ratio

ALLO1.19x

OVID2.21x

P/FCF Ratio

ALLON/A

OVIDN/A

EV/FCF

ALLO-4.54x

OVID-8.18x

PEG Ratio

ALLON/A

OVIDN/A

Forward P/E (NTM)

ALLON/A

OVIDN/A

Forward P/S (NTM)

ALLO39,713.68x

OVID1,284.26x

Revenue (TTM)

ALLO$5M

OVID$2M

Revenue Growth (YoY)

ALLON/A

OVID-76.2%

Forward Rev Growth

ALLO219.7%

OVID-72.6%

Gross Margin (TTM)

ALLO0.0%

OVID0.0%

Operating Margin (TTM)

ALLO0.0%

OVID0.0%

EBITDA Margin (TTM)

ALLO-2703.1%

OVID-3681.4%

Net Margin (TTM)

ALLO-2648.4%

OVID-2178.9%

FCF Margin (TTM)

ALLO-2211.2%

OVID-3460.1%

Net Income (TTM)

ALLO$-123M

OVID$-34M

FCF (TTM)

ALLO$-103M

OVID$-55M

EPS (TTM)

ALLO-$0.37

OVID-$0.17

ROE (TTM)

ALLO-3531.0%

OVID-2364.0%

ROA (TTM)

ALLO-2622.0%

OVID-2052.0%

ROIC (TTM)

ALLO-3531.0%

OVID-2364.0%

Cash

ALLO$39M

OVID$11M

Debt

ALLO$0

OVID$0

Net Cash/Debt

ALLO$39M

OVID$11M

Current Ratio (TTM)

ALLO10.72x

OVID12.39x

Quick Ratio (TTM)

ALLO10.55x

OVID11.75x

Debt/Equity (TTM)

ALLO0.00x

OVID0.00x

Debt/Assets (TTM)

ALLO0.0%

OVID0.0%

Interest Coverage (TTM)

ALLON/A

OVIDN/A

Net Debt/EBITDA (TTM)

ALLO0.00x

OVID0.00x

Beta

ALLO0.75

OVID0.28

52W Performance

ALLO-0.7%

OVID55.7%

YTD Performance

ALLO8.1%

OVID39.8%

% from 52W High

ALLO-67.3%

OVID-20.8%

% from 52W Low

ALLO40.4%

OVID108.5%

Asset Turnover (TTM)

ALLO0.01x

OVID0.01x

FCF Yield (TTM)

ALLO-20.4%

OVID-11.9%

Earnings Yield (TTM)

ALLO-24.4%

OVID-7.5%

Dividend Yield (TTM)

ALLON/A

OVIDN/A

Rule of 40

ALLO-2,211.2

OVID-3,536.3

EV/GP/RG

ALLON/A

OVIDN/A

Ticker research

View ALLO research View OVID research

Metric	ALLO Allogene Therapeutics Inc	OVID Ovid Therapeutics Inc
Market & Valuation
Market Cap	$504M	$459M
Enterprise Value	$465M	$448M
Price	$1.46	$2.46
P/E Ratio	N/A	N/A
P/S Ratio	108.60x	290.04x
EV/Sales	100.28x	282.89x
EV/EBITDA	0.00x	3.65x
P/B Ratio	1.19x	2.21x
P/FCF Ratio	N/A	N/A
EV/FCF	-4.54x	-8.18x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	39,713.68x	1,284.26x
Revenue & Growth
Revenue (TTM)	$5M	$2M
Revenue Growth (YoY)	N/A	-76.2%
Forward Rev Growth	219.7%	-72.6%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-2703.1%	-3681.4%
Net Margin (TTM)	-2648.4%	-2178.9%
FCF Margin (TTM)	-2211.2%	-3460.1%
Net Income (TTM)	$-123M	$-34M
FCF (TTM)	$-103M	$-55M
EPS (TTM)	-$0.37	-$0.17
ROE (TTM)	-3531.0%	-2364.0%
ROA (TTM)	-2622.0%	-2052.0%
ROIC (TTM)	-3531.0%	-2364.0%
Financial Health
Cash	$39M	$11M
Debt	$0	$0
Net Cash/Debt	$39M	$11M
Current Ratio (TTM)	10.72x	12.39x
Quick Ratio (TTM)	10.55x	11.75x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.75	0.28
52W Performance	-0.7%	55.7%
YTD Performance	8.1%	39.8%
% from 52W High	-67.3%	-20.8%
% from 52W Low	40.4%	108.5%
Efficiency & Yields
Asset Turnover (TTM)	0.01x	0.01x
FCF Yield (TTM)	-20.4%	-11.9%
Earnings Yield (TTM)	-24.4%	-7.5%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-2,211.2	-3,536.3
EV/GP/RG	N/A	N/A
Ticker research	View ALLO research	View OVID research